We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




New Tool Exposes Hidden Cancer DNA Changes Driving Treatment Resistance

By LabMedica International staff writers
Posted on 07 Aug 2025

Some of the most damaging genetic changes in cancer are also the most difficult to detect. More...

Structural alterations buried deep within a tumor's DNA can drive aggressive growth and evade traditional testing methods, especially when tumor samples are small or degraded. These hidden genomic changes can interfere with accurate diagnosis and hinder the development of effective treatment strategies. Now, researchers have developed a new tool that exposes previously invisible layers of genomic instability and provides insights into how tumors might behave and respond to treatment.

The new tool, named BACDAC, has been developed by researchers at Mayo Clinic (Rochester, MN, USA) to identify signs of genomic instability using whole-genome DNA sequencing, even in low-purity or low-coverage tumor samples. At the heart of BACDAC's functionality is the concept of ploidy, or the number of complete chromosome sets in a cell. While healthy cells contain two sets of chromosomes, cancer cells often exhibit abnormal changes such as whole-genome doubling, a phenomenon that disrupts chromosomal balance and enables uncontrolled tumor growth.

BACDAC also features a unique visual interface known as the Constellation Plot, which provides a clear and intuitive summary of a tumor’s genomic landscape, helping pathologists and researchers determine whether a tumor’s chromosomes are stable or disrupted. The researchers validated BACDAC by applying it to over 650 tumors across 12 different cancer types. The findings, published in the journal Genome Biology, show that the tool successfully detected indicators of whole-genome doubling, a structural abnormality frequently associated with aggressive tumors and resistance to therapy.

The team now plans to further validate BACDAC and develop it into a clinically deployable diagnostic platform. By offering a clearer view of complex genomic alterations, this tool could inform more personalized cancer treatments and improve outcomes for patients facing hard-to-treat cancers.

"This tool lets us see a layer of the genome that's been invisible until now. We've spent decades studying the biology of genomic instability. This is the first time we've been able to translate that knowledge into a tool that works at scale, " said George Vasmatzis, Ph.D., lead author of the study.

Related Links:
Mayo Clinic


New
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Gel Cards
DG Gel Cards
New
Gold Member
Hematology Analyzer
Medonic M32B
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more

Microbiology

view channel
Image: New diagnostics could predict a woman’s risk of a common sexually transmitted infection (Photo courtesy of 123RF)

New Markers Could Predict Risk of Severe Chlamydia Infection

Chlamydia trachomatis is a common sexually transmitted infection that can cause pelvic inflammatory disease, infertility, and other reproductive complications when it spreads to the upper genital tract.... Read more

Technology

view channel
Image: The sensor can help diagnose diabetes and prediabetes on-site in a few minutes using just a breath sample (Photo courtesy of Larry Cheng/Penn State)

Graphene-Based Sensor Uses Breath Sample to Identify Diabetes and Prediabetes in Minutes

About 37 million U.S. adults live with diabetes, and one in five is unaware of their condition. Diagnosing diabetes often requires blood draws or lab visits, which are costly and inconvenient.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.